Almost two years after abandoning its vaccine thanks to false positive HIV test results, the University of Queensland is entering human trials again on its homegrown savour from COVID.
Devastated. That is the word Professor Paul Young from the University of Queensland uses to describe the canning of Australia s most promising COVID-19 vaccine. Although the vaccine s revolutionary molecular clamp technology returned a robust immune response to coronavirus in 216 trial recipients in the Phase 1 trial, volunteers were warned that fragments of a protein derived from the HIV virus could produce antibodies, or a partial immune response to HIV. Although there was no possibility the participants could acquire HIV, the vaccine had the potential to interfere with existing HIV testing procedures. Dr Marianne Gillard, Minister Kate Jones, Professor of Virology Paul Young (centre), Dr Keith Chappell, and Dr Dan Watterson, in the Molecular Virology Lab. Picture: Liam Kidston
UQ team devastated by halt to COVID-19 vaccine | Coffs Coast Advocate coffscoastadvocate.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from coffscoastadvocate.com.au Daily Mail and Mail on Sunday newspapers.